Hong Kong Jobs

Mstone Partners Healthcare Limited engages in procuring, incubating, developing and commercializing bio-technologies in a holding company structure (“Mstone Platform” or “Platform”) with focus on rare, pediatric and repurposed drugs, neurodegenerative disorders and innovative technologies for targeted indications. Mstone Platform currently owns a number of portfolio companies under its control and will continuously establish such portfolio companies (the “Portfolio Companies”);

Forest Hills Partners Hong Kong Limited is one of the portfolio companies engages in both therapeutic drug development in neurodegenerative disorders (“Neuro-Med Division”) and R&D, manufacture and sale of medical devices and their related cosmeceutical products (“Cos-Med Division”).

Cos-Med Division develops and provides high-quality health and medical aesthetic products manufactured by its subsidiary and other partners in Korea, including injectable dermal HA/PN/PDRN fillers, mesotherapy, a variety of medical devices and cosmeceuticals for distribution in global markets.